Alpha Lipoic Acid for Weight Loss and Metabolism
Alpha lipoic acid for weight loss and metabolism: the real meta-analysis effect size, sex-based response differences, and honest expectations.
Read MoreSkip to the content
Alpha lipoic acid for weight loss and metabolism: the real meta-analysis effect size, sex-based response differences, and honest expectations.
Read More
Alpha lipoic acid side effects and who should avoid it: hypoglycemia risk, thiamine cofactor competition, thyroid medication timing, and safe-use guidance.
Read More
How much alpha lipoic acid to take per day: the 300-1800 mg clinical range, timing on an empty stomach, and how to split doses.
Read More
R-ALA versus standard racemic alpha lipoic acid: what the pharmacokinetic data actually shows, and why most clinical trials used the racemic R/S form.
Read More
Alpha lipoic acid for diabetes and blood sugar: the complementary-only evidence, hypoglycemia risk with diabetes medication, and how to use it safely.
Read More
Alpha lipoic acid for neuropathy and nerve health: what the ALADIN and NATHAN 1 trials found, oral versus IV bioavailability, and realistic expectations.
Read More
Alpha lipoic acid benefits graded by evidence strength: neuropathy, blood sugar, antioxidant support and more, plus where the research is strong and where it is weak.
Read More
A complete guide to alpha lipoic acid: what the racemic R/S form means, what benefits the evidence actually supports, and how to choose a quality supplement.
Read More
Ginkgo biloba for anxiety, mood and sleep: the Woelk 2007 generalized anxiety trial, the thinner evidence for depression and sleep, and how to use it responsibly.
Read More
Ginkgo biloba side effects and who should avoid it: bleeding risk and drug interactions, pre-surgery timing, seizure-disorder caution, and safe-use guidance.
Read More
How much ginkgo biloba to take per day: the standardized EGb 761 doses used in research, onset timeline, and how raw leaf capsules compare to extract.
Read More
Ginkgo biloba for circulation and blood flow: the PAF and microcirculation mechanism, the intermittent claudication evidence, and why it is not a blood pressure drug.
Read More